Hiroyoshi Suzuki

14.1k total citations · 2 hit papers
401 papers, 8.0k citations indexed

About

Hiroyoshi Suzuki is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hiroyoshi Suzuki has authored 401 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 200 papers in Pulmonary and Respiratory Medicine, 83 papers in Oncology and 76 papers in Surgery. Recurrent topics in Hiroyoshi Suzuki's work include Prostate Cancer Treatment and Research (132 papers), Prostate Cancer Diagnosis and Treatment (69 papers) and Radiopharmaceutical Chemistry and Applications (34 papers). Hiroyoshi Suzuki is often cited by papers focused on Prostate Cancer Treatment and Research (132 papers), Prostate Cancer Diagnosis and Treatment (69 papers) and Radiopharmaceutical Chemistry and Applications (34 papers). Hiroyoshi Suzuki collaborates with scholars based in Japan, United States and Germany. Hiroyoshi Suzuki's co-authors include Tomohiko Ichikawa, Akira Komiya, Haruo Itô, Takashi Imamoto, Naoto Kamiya, Jun Shimazaki, Koichiro Akakura, Ryuichi Yatani, Takeshi Ueda and Yukio Naya and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Hiroyoshi Suzuki

373 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression

1998 526 citations Hiroyoshi Suzuki et al. profile →
Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial

2023 99 citations Hiroyoshi Suzuki et al. profile →

Peers

Countries citing papers authored by Hiroyoshi Suzuki

Since Specialization

Citations

This map shows the geographic impact of Hiroyoshi Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyoshi Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyoshi Suzuki more than expected).

Fields of papers citing papers by Hiroyoshi Suzuki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyoshi Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyoshi Suzuki. The network helps show where Hiroyoshi Suzuki may publish in the future.

Co-authorship network of co-authors of Hiroyoshi Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyoshi Suzuki. A scholar is included among the top collaborators of Hiroyoshi Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyoshi Suzuki. Hiroyoshi Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate Cancer 2025 ·European Urology Oncology ·Niven Mehra, Emmanuel S. Antonarakis, Se Hoon Park, Jeffrey C. Goh, Ray McDermott, (unknown), Peter C.C. Fong, Richard Greil, Maria De Santis, Patricio Yañez, Eric Yi‐Hsiu Huang, Stephen Begbie, Felipe Rey, Gero Kramer, Hiroyoshi Suzuki, (unknown), Sameer R. Ghate, Yi Cui, Christian Hosius, Evan Y. Yu	1
2	Risk-adapted durations of hormone therapy combined with radiotherapy for prostate cancer 2025 ·(unknown), (unknown), Ryusuke Ikeda, (unknown), Yuta Suzuki, (unknown), (unknown), (unknown), (unknown), Takumi Endo, Naoto Kamiya, Hiroyoshi Suzuki	0
3	Precision Care for Hereditary Urologic Cancers: Genetic Testing, Counseling, Surveillance, and Therapeutic Implications 2025 ·Current Oncology ·(unknown), (unknown), Ryusuke Ikeda, (unknown), (unknown), Yuta Suzuki, (unknown), (unknown), (unknown), Takumi Endo, Naoto Kamiya, Hiroyoshi Suzuki	0
4	Impact of COVID-19 on Ureteroscopy Management of Urolithiasis: Retrospective Comparative Study Before and After Pandemic 2025 ·Applied Sciences ·(unknown), (unknown), (unknown), (unknown), Yuta Suzuki, (unknown), (unknown), (unknown), Takumi Endo, Naoto Kamiya, Hiroyoshi Suzuki	0
5	Navigating Therapeutic Landscapes in Urothelial Cancer: From Chemotherapy to Precision Immuno-Oncology 2025 ·Cancers ·(unknown), (unknown), Ryusuke Ikeda, (unknown), (unknown), Yuta Suzuki, (unknown), (unknown), (unknown), Takumi Endo, Naoto Kamiya, Hiroyoshi Suzuki	1
6	Impact of the COVID ‐19 Pandemic on Prostate Cancer: Perturbations in Screening and Diagnostic Patterns 2025 ·International Journal of Urology ·(unknown), (unknown), (unknown), Yuta Suzuki, (unknown), (unknown), (unknown), (unknown), Takumi Endo, Naoto Kamiya, Nobuyuki Hiruta, Hiroyoshi Suzuki	2
7	Development, Validation, and Clinical Utility of a Nomogram for Urological Tumors: How to Build the Best Predictive Model 2025 ·International Journal of Urology ·(unknown), (unknown), (unknown), Yuta Suzuki, (unknown), (unknown), (unknown), (unknown), Takumi Endo, Naoto Kamiya, Hiroyoshi Suzuki	3
8	Predicting Urosepsis in Ureteral Calculi: External Validation of Hu’s Nomogram and Identification of Novel Risk Factors 2025 ·Diagnostics ·(unknown), (unknown), (unknown), (unknown), Yuta Suzuki, (unknown), (unknown), (unknown), Takumi Endo, Naoto Kamiya, Hiroyoshi Suzuki	0
9	Androgen Receptor Signaling Inhibitors in Non‐Metastatic Castration‐Resistant Prostate Cancer in Japan: The ARASHI Study 2025 ·International Journal of Urology ·(unknown), Nasreen Khan, (unknown), (unknown), Guifang Chen, Mercedeh Ghadessi, Niculae Constantinovici, (unknown), Hiroyoshi Suzuki	0
10	Multidisciplinary Treatment for Lymphorrhea and Chylorrhea Following Lymph Node Dissection for Genitourinary Cancer 2025 ·Cancers ·Naoto Kamiya, (unknown), Taro Okazaki, (unknown), Yuta Suzuki, (unknown), (unknown), (unknown), (unknown), (unknown), Takumi Endo, (unknown), Nobuyuki Hiruta, Hiroyoshi Suzuki	0
11	The changing seabird fauna of Minamitorishima (Marcus Island), Ogasawara Islands, subtropical Japan 2024 ·Japanese Journal of Ornithology ·Kazuto Kawakami, Hiroyoshi Suzuki, (unknown)	0
12	Triple-disease etiology is common for LUTS in octogenarians: a neuro-urological approach 2021 ·International Urology and Nephrology ·(unknown), Ryuji Sakakibara, Fuyuki Tateno, Tsuyoshi Ogata, Yosuke Aiba, Hiroyoshi Suzuki, Masashi Yano	3
13	Carotid web leads to new thrombus formation: computational fluid dynamic analysis coupled with histological evidence 2020 ·Acta Neurochirurgica ·(unknown), Toshiki Endo, Hiroyoshi Suzuki, Shin‐ichiro Sugiyama, Kaoru Endô, Ryo Itabashi, Miki Fujimura, Teiji Tominaga	23
14	Female detrusor underactivity: Two uterine leiomyoma cases 2020 ·IJU Case Reports ·(unknown), Ryuji Sakakibara, (unknown), Naoki Takeshita, Akiko Takashima, Yosuke Aiba, Fuyuki Tateno, Hiroyoshi Suzuki, Masashi Yano	3
15	OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor‐positive breast carcinoma 2018 ·Cancer Science ·(unknown), Kiyoshi Takagi, Hiroyoshi Suzuki, Ai Sato, Yoshiaki Onodera, Yasuhiro Miki, Minako Sakurai, Takanori Watanabe, Kazuhiro Sakamoto, Ryuichi Yoshida, Takanori Ishida, Hironobu Sasano, Takashi Suzuki	38
16	Urodynamic findings in patients with Creutzfeldt–Jakob disease: a case report 2016 ·International Urology and Nephrology ·Masashi Yano, Ryuji Sakakibara, Fuyuki Tateno, Osamu Takahashi, Haruka Nakamura, Megumi Sugiyama, (unknown), (unknown), Naoto Kamiya, Hiroyoshi Suzuki	2
17	Giant Epithelial-Myoepithelial Carcinoma of the Parotid Gland 2011 ·Practica Oto-Rhino-Laryngologica ·Jun Suzuki, Sho Hashimoto, Kenichi Watanabe, Kaoru Takahashi, Hiroyoshi Suzuki	0
18	Usefulness of intensive training for laparoscopic radical prostatectomy at an experienced institution 2007 ·(unknown), Yukihiro Kondo, (unknown), (unknown), Yasutomo Suzuki, (unknown), Hiroyoshi Suzuki, Go Kimura, Tomohiko Ichikawa, Kazuhiro Yoshida, Taiji Nishimura	1
19	Liposarcoma of the Hypopharynx; A Case Report. 1998 ·Practica Oto-Rhino-Laryngologica ·Seiichiro Nakabayashi, Hideaki Suzuki, Masayuki Furukawa, (unknown), (unknown), Hiroyoshi Suzuki	0
20	STUDY OF THE GASTRIC MUCOSAL ATROPHIC PATTERN AND THE COMPLICATION OF GASTRIC CANCER IN PERNICIOUS ANEMIA PATIENS AND THEIR FAMILY MEMBERS 1981 ·Acta gastro-enterologica belgica ·(unknown), Masataka Maruyama, Shinichiro Watanabe, Keiko Shiratori, Yukiko Ota, Hiroyoshi Suzuki, Tadayoshi Takemoto	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact